NCT02143609View on ClinicalTrials.gov

Patients With Chronic Obstructive Pulmonary Disease at Altitude - Effect of Nocturnal Oxygen on Exercise Performance

PHASE4CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Chronic Obstructive Pulmonary Disease (COPD)
Interventions
DRUG

oxygen

Nocturnal nasal oxygen during stay at 2048 m

DRUG

sham oxygen (room air)

Sham oxygen (room air) via nasal cannula, 3 L/min, at 2048 m

Trial Locations (1)

CH-8091

University Hospital Zurich, Pulmonary Division, Zurich

All Listed Sponsors
lead

University of Zurich

OTHER

NCT02143609 - Patients With Chronic Obstructive Pulmonary Disease at Altitude - Effect of Nocturnal Oxygen on Exercise Performance | Biotech Hunter | Biotech Hunter